glp-1 in cleveland Could medications help slow cancer progression?⁣ ⁣ A new Clinic study found those taking GLP-1s were less likely to develop stage IV disease several cancer types, when compared to GLP-1 meds slow cancer progression

Compared with liraglutide alone, the combined treatment decreased time to complete a stair climb test by 1.2 s [95% confidence interval 0.61.9] (corresponding to 8.6%) and improved peak oxygen consumption by 3.0 mL/min/kg fat-free mass [95% confidence interval 0.55.5]

Furthermore, a member of Firmicutes, Faecalibacterium prausnitzii, seems to be reduced in these patients, compared to healthy controls

doi: 10.1016/j.lfs.2019.04.045

However, another group found that the presence of the T1D-linked genetic variant of rs2281808 is associated with reduced SIRP expression in CD8+ T cells, an increased effector state with a lower T cell activation threshold, and a reduction in gene expression associated with long-term functional memory T cell formation (84)

Entre las novedades ms destacadas figuran los agonistas del receptor GLP-1 para la diabetes de tipo 2, los anlogos de insulina de accin rpida y los tratamientos contra la fibrosis qustica y el cncer

The liver produces and uses free radicals for detoxification, while white blood cells send free radicals to destroy bacteria, viruses and damaged cells